scispace - formally typeset
D

Dilmurodjon Eshmuminov

Researcher at University of Zurich

Publications -  52
Citations -  995

Dilmurodjon Eshmuminov is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Machine perfusion. The author has an hindex of 12, co-authored 37 publications receiving 554 citations.

Papers
More filters
Journal ArticleDOI

An integrated perfusion machine preserves injured human livers for 1 week.

TL;DR: A liver perfusion machine that integrates multiple core physiological functions, including automated management of glucose levels and oxygenation, waste-product removal and hematocrit control is developed in a stepwise fashion using pig livers.
Journal ArticleDOI

Novel Real-time Prediction of Liver Graft Function During Hypothermic Oxygenated Machine Perfusion Before Liver Transplantation

TL;DR: Assessment of flavin, a marker of mitochondrial complex I injury, in the perfusate provides a fast prediction of liver graft function and loss during ex situ MP before implantation, which may have high clinical relevance, as liver grafts from extended DBD or DCD donors carry considerable risks for recipients.
Journal ArticleDOI

Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture.

TL;DR: A widely accepted definition of PT is lacking and a correlation with the risk of POPF is based on subjective evaluation, which is still acceptable, and classification of PT into 2-groups is more reasonable than classification into 3-groups.
Journal ArticleDOI

Transplantation of a human liver following 3 days of ex situ normothermic preservation

TL;DR: The transplantation of a human liver discarded by all centers is reported, which could be preserved for several days using ex situ normothermic machine perfusion and exhibited normal function, with minimal reperfusion injury and the need for only a minimal immunosuppressive regimen.